CroiValve has pulled in $4.4 million in additional financing, which it plans to use for first-in-human studies of its technology for its tricuspid coaptation valve. The money comes from both investors and a Horizon 2020 SME Instrument grant.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.